Abstract
Bullous pemphigoid and pemphigus vulgaris are blistering diseases. Our results show that expression of the integrins α6β4 α3β1is altered in both diseases: α6β4 to a greater extent in the former and α3β1 in the latter disease, respectively. Instead, the extracellular matrix examined resulted normally expressed.
Keywords: bullous pemphigoid, pemphigus vulgaris, integrins
Letters in Drug Design & Discovery
Title: Expression of α6β4 and α3β1 Integrins in Bullous Pemphigoid and Pemphigus Vulgaris
Volume: 2 Issue: 3
Author(s): G. Giannelli, C. Foti, C. Divella, F. Marinosci, D. Bonamonte and S. Antonaci
Affiliation:
Keywords: bullous pemphigoid, pemphigus vulgaris, integrins
Abstract: Bullous pemphigoid and pemphigus vulgaris are blistering diseases. Our results show that expression of the integrins α6β4 α3β1is altered in both diseases: α6β4 to a greater extent in the former and α3β1 in the latter disease, respectively. Instead, the extracellular matrix examined resulted normally expressed.
Export Options
About this article
Cite this article as:
Giannelli G., Foti C., Divella C., Marinosci F., Bonamonte D. and Antonaci S., Expression of α6β4 and α3β1 Integrins in Bullous Pemphigoid and Pemphigus Vulgaris, Letters in Drug Design & Discovery 2005; 2 (3) . https://dx.doi.org/10.2174/1570180053765084
DOI https://dx.doi.org/10.2174/1570180053765084 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
GSK3 Inhibitors in the Therapeutic Development of Diabetes, Cancer and Neurodegeneration: Past, Present and Future
Current Pharmaceutical Design Development of Linker-Conjugated Nanosize Lipid Vesicles: A Strategy for Cell Selective Treatment in Breast Cancer
Current Cancer Drug Targets Adhesion Molecules in Lung Cancer: Implications in the Pathogenesis and Management
Current Pharmaceutical Design Carrier Deformability in Drug Delivery
Current Pharmaceutical Design Studies on Chloride Channels and their Modulators
Current Topics in Medicinal Chemistry Gynaecological Cancer Diagnostics: 99mTc-Cisplatin Complex as a Future Approach for Early, Prompt and Efficient Diagnosis of Gynaecological Cancer
Current Medical Imaging Angiogenesis Markers in Gynecological Tumors and Patents for Anti- Angiogenic Approach: Review
Recent Patents on Anti-Cancer Drug Discovery Tumor Bone Diseases: Molecular Mechanisms and Opportunities for Novel Treatments
Current Medicinal Chemistry - Anti-Cancer Agents Flavonoids: Prospective Drug Candidates
Mini-Reviews in Medicinal Chemistry Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of Oncogenesis
Current Cancer Drug Targets Treatment of Acute Hypercalcemia
Medicinal Chemistry Targeted Drug Delivery System for Platinum-based Anticancer Drugs
Mini-Reviews in Medicinal Chemistry Applications of Computed Tomography, Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy for Planning External Beam Radiotherapy
Current Medical Imaging EBV-Related Malignancies, Outcomes and Novel Prevention Strategies
Infectious Disorders - Drug Targets Disruption of Cell Death Signaling in Cancer: Impact on Disease Prognosis and Response to Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Dietary Phytochemicals in Chemoprevention of Cancer
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Ellipticines as DNA-Targeted Chemotherapeutics
Current Medicinal Chemistry Receptor Tyrosine Kinases Take a Direct Route to Mitochondria: An Overview
Current Protein & Peptide Science Cytotoxic, Apoptotic and DNA Synthesis Inhibitory Effects of Some Thiazole Derivatives
Letters in Drug Design & Discovery Curcumin Nanoemulsions Stabilized with Modified Phosphatidylcholine on Skin Carcinogenesis Protocol
Current Drug Metabolism